MYC and neuroblastoma: In spite of the cytotoxic activity against NB cells at higher doses, JQ1 is enable to upregulate the expression of activating ligands at pre-apoptotic dose, by impairing c-MYC levels, keeping impaired p53 function and downmodulating ROS levels.